Drug profile · INN
bethanechol chloride
MYOTONACHOL
bethanechol chloride (MYOTONACHOL) is a muscarinic acetylcholine receptor m3 agonist. Associated with Odyssey Therapeutics. Route of administration: injection. Current US regulatory status: approved.
Drug details — bethanechol chloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
bethanechol chloride (MYOTONACHOL) is a muscarinic acetylcholine receptor m3 agonist. Associated with Odyssey Therapeutics. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscarinic acetylcholine receptor M3 agonist
Primary target: Muscarinic acetylcholine receptor M2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is bethanechol chloride?
bethanechol chloride (MYOTONACHOL) is a muscarinic acetylcholine receptor m3 agonist. Associated with Odyssey Therapeutics. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for bethanechol chloride?
MYOTONACHOL is a marketed brand name for bethanechol chloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bethanechol chloride?
bethanechol chloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.